Skip to Main Content

Author Details

Padma S Rajagopal
National Cancer Institute, National Institutes of Health
2014
19
9
PMIDPaper TitleJournal TitlePublished Year
36513065Clinically oriented prediction of patient response to targeted and immunotherapies from the tumor transcriptome.Med2023
38076973Charting the transcriptomic landscape of primary and metastatic cancers in relation to their origin and target normal tissues.bioRxiv2023
37425784Network-based approach elucidates critical genes in BRCA subtypes and chemotherapy response in Triple Negative Breast Cancer.bioRxiv2023
35101336Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC).Genet Med2022
36497367Sex Biases in Cancer and Autoimmune Disease Incidence Are Strongly Positively Correlated with Mitochondrial Gene Expression across Human Tissues.Cancers (Basel)2022
36063163Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC).Genet Med2022
36383380Characterization of Oncology Clinical Trials Using Germline Genetic Data.JAMA Netw Open2022
35921407Cross-species identification of cancer resistance-associated genes that may mediate human cancer risk.Sci Adv2022
34836952Whole-genome analysis of Nigerian patients with breast cancer reveals ethnic-driven somatic evolution and distinct genomic subtypes.Nat Commun2021
32864637Black Lives Matter Worldwide: Retooling Precision Oncology for True Equity of Cancer Care.Cell Rep Med2020
32917697PhenomeXcan: Mapping the genome to the phenome through the transcriptome.Sci Adv2020
30408496Development and Pilot Testing of a Simulation to Study How Physicians Facilitate Surrogate Decision Making Based on Critically Ill Patients' Values and Preferences.J Pain Symptom Manage2019
31246531The Time for Mainstreaming Germline Testing for Patients With Breast Cancer Is Now.J Clin Oncol2019
31434110USPSTF Recommendations for BRCA1 and BRCA2 Testing in the Context of a Transformative National Cancer Control Plan.JAMA Netw Open2019
31147983Employment trends in young women following a breast cancer diagnosis.Breast Cancer Res Treat2019
29684228Point: LHRH Agonists vs Ovarian Ablation for Suppression of Ovarian Function in Premenopausal Breast Cancer Patients. Starting With Reversible OFS Using LHRH Agonists Is Preferred for Most Patients.Oncology (Williston Park)2018
28757653Distinct Pattern of Metastases in Patients with Invasive Lobular Carcinoma of the Breast.Geburtshilfe Frauenheilkd2017
24018020Adjuvant chemotherapy for invasive bladder cancer: a 2013 updated systematic review and meta-analysis of randomized trials.Eur Urol2014
25841696Chemotherapy for advanced cancers.Ann Palliat Med2014
  • 1 - 19 of 19

Recommended Authors

Leuven Cancer Institute and University Hospitals Leuven
Career Start Year 2015
Number of shared co-authors 2
Mayo Clinic Arizona
Career Start Year 2015
Number of shared co-authors 0
Mayo Clinic
Career Start Year 2010
Number of shared co-authors 1
Dana-Farber Cancer Institute
Career Start Year 2009
Number of shared co-authors 12
University of Genoa and Ospedale Policlinico San Martino
Career Start Year 2008
Number of shared co-authors 1
Mayo Clinic
Career Start Year 2007
Number of shared co-authors 3
Center for Drug Evaluation and Research
Career Start Year 2007
Number of shared co-authors 1
Mayo Clinic
Career Start Year 2006
Number of shared co-authors 1
Mater Misericordiae University Hospital
Career Start Year 2006
Number of shared co-authors 1
Clinical Investigations Branch, National Cancer Institute
Career Start Year 2004
Number of shared co-authors 2
Massachusetts General Hospital Cancer Center
Career Start Year 2004
Number of shared co-authors 0
Princess Margaret Cancer Centre
Career Start Year 2003
Number of shared co-authors 0
Massachusetts General Hospital
Career Start Year 2003
Number of shared co-authors 1
Mayo Clinic
Career Start Year 2002
Number of shared co-authors 4
Otto-Friedrich-University Bamberg
Career Start Year 2002
Number of shared co-authors 3
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2002
Number of shared co-authors 3
Department of Medicine and Moores Cancer Center, University of California San Diego
Career Start Year 2000
Number of shared co-authors 0
Dana-Farber Cancer Institute
Career Start Year 2000
Number of shared co-authors 5
The University of Texas MD Anderson Cancer Center
Career Start Year 1999
Number of shared co-authors 5
Familial Cancer Centre Peter MacCallum Cancer Centre Parkville Victoria 0 Australia.
Career Start Year 1998
Number of shared co-authors 2
Institute for Human Genetics, University of California san francisco
Career Start Year 1998
Number of shared co-authors 5
Center for Research and Analytics, American Society of Clinical Oncology
Career Start Year 1997
Number of shared co-authors 1
Francis Crick Institute
Career Start Year 1997
Number of shared co-authors 7
University of Milan
Career Start Year 1996
Number of shared co-authors 4
Massachusetts General Hospital
Career Start Year 1995
Number of shared co-authors 3
Massachusetts General Hospital, Harvard Medical School
Career Start Year 1993
Number of shared co-authors 1
University of California los angeles
Career Start Year 1991
Number of shared co-authors 3
University of Texas MD Anderson Cancer Center
Career Start Year 1990
Number of shared co-authors 11
Dana-Farber Cancer Institute
Career Start Year 1985
Number of shared co-authors 3
UCL Great Ormond Street Institute of Child Health, University College London
Career Start Year 1976
Number of shared co-authors 1

Collaborators

National Cancer Institute
Co-authored papers 4
National Cancer Institute
Co-authored papers 3
National Cancer Institute, National Institutes of Health
Co-authored papers 3
German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT)
Co-authored papers 2
Children's Hospital Los Angeles
Co-authored papers 2
Centene Center for Health Transformation, Centene Corporation
Co-authored papers 2
National Cancer Institute
Co-authored papers 2
Mayo Clinic Foundation
Co-authored papers 2
Hospital Israelita Albert Einstein
Co-authored papers 2
German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT)
Co-authored papers 2
Innovation Center for Biomedical Informatics, Georgetown University Medical Center
Co-authored papers 2
National Cancer Center Hospital
Co-authored papers 2
Association for Molecular Pathology
Co-authored papers 2
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 2
Washington University School of Medicine
Co-authored papers 2
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
University of Cincinnati College of Medicine
Co-authored papers 2
Baylor College of Medicine
Co-authored papers 2
Universitat Pompeu Fabra
Co-authored papers 2
Vanderbilt University Medical Center
Co-authored papers 2
Dana-Farber Cancer Institute
Co-authored papers 2
Washington University
Co-authored papers 2
McDonnell Genome Institute, Washington University in St Louis School of Medicine
Co-authored papers 2
Genomic Medicine Institute, Cleveland Clinic Lerner Research Institute
Co-authored papers 2
Washington University
Co-authored papers 2
German Cancer Consortium and German Cancer Research Center
Co-authored papers 2
Mayo Clinic
Co-authored papers 2
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Mayo Clinic
Co-authored papers 2
Indiana University School of Medicine
Co-authored papers 2